Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.012 0.7
mRNA L-685458 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.028 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.018 0.7
Download CSV